Matthew D Perry Cti Biopharma Corp (CTIC) insider trading activity

CTIC Quotes by TradingView

Matthew D Perry is Director of CTI BIOPHARMA CORP. Currently has a direct ownership of 0 shares of CTIC, which is worth approximately $0. The most recent transaction as insider was on Jun 26, 2023, when has been sold 43,139 shares (Common Stock) at a price of $9.1 per share, resulting in proceeds of $392,564. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

MATTHEW D PERRY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 26 2023
SELL
Disposition due to a tender of shares in a change of control transaction
$392,564 $9.1 p/Share
43,139 Reduced 100.0%
0 Common Stock

Also insider at

XOMA
XOMA Corp Healthcare
MDP

Matthew D Perry

Director
Seattle, WA

Track Institutional and Insider Activities on CTIC

Follow CTI BIOPHARMA CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTIC shares.

Notify only if

Insider Trading

Get notified when an Cti Biopharma Corp insider buys or sells CTIC shares.

Notify only if

News

Receive news related to CTI BIOPHARMA CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTIC